Artivion | CRY - Des Atouts

Prix De L'Action
37.04
Variation Quotidienne
-0.82 -2.17%
Mensuellement
-6.49%
Annuel
53.18%
Q1 Prévisions
35.91




Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
Accuray USD 456.82M 13.42M 2025-09
AngioDynamics USD 285.41M 6.14M 2025-02
Artivion USD 857.66M 19.27M 2025-09
AtriCure USD 654.18M 18.74M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Inogen USD 307.01M 5.03M 2025-09
Integra LifeSciences USD 3.6B 44.45M 2025-12
J&J USD 199.21B 6.39B 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 832.61M 4.55M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
ResMed USD 8.5B 195.02M 2025-12
Stryker USD 47.84B 787M 2025-12
Surmodics USD 178.56M 1.15M 2024-09
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Trinity Biotech USD 103.71M 4.08M 2025-09